We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

19 hedge funds and large institutions have $60.6M invested in Eledon Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,077% more capital invested

Capital invested by funds: $2.78M → $60.6M (+$57.8M)

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0.65% more ownership

Funds ownership: 2.1% → 2.75% (+0.65%)

5% less funds holding

Funds holding: 20 → 19 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$947K
2
ACM
Asymmetry Capital Management
California
+$596K
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$356K
4
Renaissance Technologies
Renaissance Technologies
New York
+$67.2K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$33.9K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$42K
2
Citadel Advisors
Citadel Advisors
Florida
-$25K
3
Jane Street
Jane Street
New York
-$19K
4
TSS
Two Sigma Securities
New York
-$15K
5
BCM
Bayesian Capital Management
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$54.4M – – –
BI
2
BVF Inc
California
$3.34M +$947K +96,159 +97%
ACM
3
Asymmetry Capital Management
California
$1.03M +$596K +60,495 New
Renaissance Technologies
4
Renaissance Technologies
New York
$720K +$67.2K +6,826 +19%
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$618K +$356K +36,111 New
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$162K +$33.9K +3,442 +57%
Vanguard Group
7
Vanguard Group
Pennsylvania
$52K – – –
Thrivent Financial for Lutherans
8
Thrivent Financial for Lutherans
Minnesota
$43K – – –
Bank of America
9
Bank of America
North Carolina
$32K +$18.1K +1,833 New
Rockefeller Capital Management
10
Rockefeller Capital Management
New York
$28K – – –
Northern Trust
11
Northern Trust
Illinois
$22K +$6.44K +654 +102%
TRCT
12
Tower Research Capital (TRC)
New York
$21K +$12.4K +1,257 New
PCM
13
Prelude Capital Management
New York
$19K +$11.1K +1,127 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$16K -$670 -68 -7%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$12K – – –
RJA
16
Raymond James & Associates
Florida
$10K +$6.02K +611 New
BlackRock
17
BlackRock
New York
$6K – – –
UBS Group
18
UBS Group
Switzerland
$4K +$2.29K +233 New
PAM
19
Panagora Asset Management
Massachusetts
$1K – – –
VF
20
Virtu Financial
New York
– -$42K -5,117 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$25K -3,016 Closed
Jane Street
22
Jane Street
New York
– -$19K -2,341 Closed
TSS
23
Two Sigma Securities
New York
– -$15K -1,869 Closed
BCM
24
Bayesian Capital Management
New York
– -$5K -645 Closed
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
– -$246 -25 Closed
1
2

ELDN Hedge Fund Activity: Q3 2020 in Review

19 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q3 2020, worth a combined $60.6M — up 2,077% from $2.78M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ELDN and 7 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 5 added.

The largest buyer was BVF Inc, adding an estimated $947K. The largest seller was Virtu Financial, exiting entirely with an estimated $42K sold.

  • 19 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q3 2020, down from 20 in Q2 2020.
  • Funds reported $60.6M of Eledon Pharmaceuticals stock for Q3 2020, up 2,077% quarter-over-quarter.
  • 7 funds opened new Eledon Pharmaceuticals positions in Q3 2020 and 8 closed out, a net change of -1 holder.
  • The largest Eledon Pharmaceuticals buyer in Q3 2020 was BVF Inc, an estimated $947K added.
  • The largest Eledon Pharmaceuticals seller in Q3 2020 was Virtu Financial, an estimated $42K sold.

Based on aggregated 13F filings for Q3 2020.